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P2X ionotropic non-selective cation channels are expressed throughout the kidney and
are activated in a paracrine or autocrine manner following the binding of extracellular ATP
and related extracellular nucleotides. Whilst there is a wealth of literature describing a
regulatory role of P2 receptors (P2R) in the kidney, there are significantly less data on the
regulatory role of P2X receptors (P2XR) compared with that described for metabotropic
P2Y. Much of the historical literature describing a role for P2XR in the kidney has focused
heavily on the role of P2X1R in the autoregulation of renal blood flow. More recently,
however, there has been a plethora of manuscripts providing compelling evidence for
additional roles for P2XR in both kidney health and disease. This review summarizes
the current evidence for the involvement of P2XR in the regulation of renal tubular and
vascular function, and highlights the novel data describing their putative roles in regulating
physiological and pathophysiological processes in the kidney.
Keywords: P2X receptor, P2 receptors, kidney, renal circulation, renal tubular transport, inborn errors, P2X7
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INTRODUCTION
Extracellular ATP and related nucleotides have been shown to
contribute to complex autocrine and/or paracrine signaling net-
works throughout the body following their activation of P2 recep-
tors (P2R; formerly termed purinoceptor; Burnstock and Knight,
2004). The P2 family of receptors is divided into metabotropic
G protein-coupled P2Y receptors (P2YR) and ionotropic ligand-
gated P2X receptors (P2XR), which act as non-selective cation
channels (Fredholm et al., 1994). There are eight pharmacolog-
ically distinct P2YR (P2Y1,2,4,6,11−14) and seven unique P2XR
subunits (P2X1-7), which can form seven homomeric assemblies,
seven established heteromeric assemblies (P2X1/2, 1/4, 1/5, 2/3,
2/6, 4/6, 4/7), as well as several predicted heteromeric assemblies.
Heterologous expression systems have been used to demonstrate
that P2XR can readily form functional trimeric or hexameric
assemblies (North, 2002). The actual number of subunits present
in native cell multimeric assemblies is still debated, however,
the trimer is favored (North, 2002). It is established that there
are an abundance of P2R in a variety of cell types throughout
the body, linked to numerous physiological processes such as
regulation of other membrane-located ion channels, cell-to-cell
communication, secretion of cytokines, metabolic processes such
as glugoneogenesis, cell proliferation, and cell death (Burnstock
and Knight, 2004).
It is perhaps not surprising that P2R are ubiquitously
expressed throughout the kidney, in both cortical and medullary
vascular and tubular compartments. They contribute to a diverse
range of physiological and pathophysiological processes and yet
the localization of specific P2R subtypes can be highly regional,
overlapping, and often debated. Much of the renal literature pub-
lished to date focuses on the role of metabotropic P2YR, and in
particular in their regulation of sodium (Na) and water transport
in the collecting duct (CD; Kishore et al., 2009; Wildman et al.,
2009; Vallon and Rieg, 2011), with P2XR being somewhat over-
looked (with the exception of their role in regulating afferent
arteriole diameter; see summary Figure 1). Arguably a dogma
exists that P2XR play little or no role in kidney function. However,
a recent glut of manuscripts provides compelling evidence for
P2XR playing key roles in the kidney. This review will discuss
the most recent advances in the field of “renal P2XR” [i.e., the
key literature of the last 3-years (2010–2013)], focusing on the
tubular and vascular localization of P2XR and their function(s)
in both the physiological and pathological setting (see summary
Figure 2).
NEW ROLES FOR P2XR IN RENAL TUBULAR TRANSPORT
Expression of P2XR varies throughout the nephron. P2X4R
and P2X6R are expressed in the proximal tubule, distal tubule,
loop of Henle and CD, making these receptor subtypes the
most widely distributed (Unwin et al., 2003). P2X1R and
P2X7R are localized predominantly in Bowman’s capsule and
the CD and are more widely distributed in vascular networks
(as discussed in the next section; Inscho et al., 2003; Vitzthum
et al., 2004; Osmond and Inscho, 2010; Crawford et al., 2011).
Immunohistochemical studies have also demonstrated low lev-
els of expression for P2X2R and P2X5R in the cortical and
medullary CDs (Turner et al., 2003; Wildman et al., 2008). The
putative roles previously described for P2XR in the nephron
have included inhibition of fluid reabsorption in the proxi-
mal tubule, inhibition of magnesium absorption in the dis-
tal tubule, and inhibition of AQP2-mediated water absorption
and modulation (inhibiting and potentiating) of ENaC-mediated
Na+ absorption/reabsorption in the CD (Bailey et al., 2012; see
summary Figure 1).
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FIGURE 1 | Summary of P2X receptor-mediated effects in the
kidney and epithelial cell lines derived from specific nephron
segments; pre-2010/11. Information taken from: Wildman and King,
2008; Bailey et al., 2012. Key: AP, denotes that the P2X receptors
are localized on the epithelial cell apical membrane; BL, denotes
localization on the basolateral membrane.
Novel data obtained from pharmacological experiments that
utilized P2XR selective agonists, complimented by studies in
knockout mice (−/−), now provide compelling evidence for a
functional role for P2XR in the medullary thick ascending limb
(mTAL) (Marques et al., 2012). It is well-established that NaCl
enters cells of the TAL via the apical Na/H exchanger and Na-
K-2Cl co-transporter and leaves the cell via basolateral Na-K-
ATPase, and nitric oxide (NO) inhibits both the Na/H exchanger
andNa-K-ATPase to regulate ion transport. Experiments to deter-
mine the effect of basolateral ATP on NaCl absorption in isolated
perfused mouse mTALs, using the electrical measurement of
equivalent short-circuit current, demonstrated that basolateral
ATP attenuated the absorptive short-circuit current (Marques
et al., 2012). Authors used P2XR selective agonists and antago-
nists to demonstrate the effect was mediated, not via P2YR as
might have been expected, but via P2XR. Experiments repro-
duced in both P2X7R−/− and P2X4R−/− concluded that the
ATP-inhibition of transport was reduced in the P2X4R−/− ani-
mals thus indicating a key role for P2X4R. This finding was
further corroborated by PCR experiments, which confirmed the
presence of P2X4R mRNA, together with P2X1R and P2X5R
mRNA in isolatedmTAL (Marques et al., 2012). In addition, com-
plimentary studies seeking to determine the factors responsible
for flow-mediated NO production in the mTAL identified ATP
as a candidate. Researchers used P2YR and P2XR selective antag-
onists to demonstrate a role for basolateral P2XR (and apical
P2YR) in ATP-mediated, flow-induced production of NO in
the mTAL (Cabral et al., 2012). Collectively, data from these
studies suggest that ATP, released by increased tubular flow
rate, acts on basolaterally-expressed P2X4R (potentially a het-
eromeric assembly, with either P2X1R or P2X5R), to increase
NO production, which ultimately inhibits NaCl reabsorption
in the mTAL. However, the mechanism by which luminal ATP
activates basolaterally-expressed P2X4 receptors is yet to be eluci-
dated.
Studies performed in our laboratory and with collaborators
have similarly identified roles for P2X4R, and potentially P2X7R,
in the regulation of Na reabsorption. However, our studies have
focused on the CD rather than the TAL. Initially using M1 cells,
an immortalized mouse cortical CD cell line, in combination
with electrophysiology techniques we identified ionotropic P2XR-
mediated channel activity (Birch et al., 2013a). Application of
ATP to outside-out patches activated single-channel openings,
from multiple receptor subtypes, with single-channel properties
similar to those of P2XR previously identified in other cell types
(Evans, 1996; Birch et al., 2013a). Characterization of the exact
Frontiers in Physiology | Renal and Epithelial Physiology September 2013 | Volume 4 | Article 262 | 2
Birch et al. P2X in the kidney
FIGURE 2 | Summary of P2X receptor-mediated effects in the
kidney and epithelial cell lines derived from specific nephron
segments; 2011–2013 inclusive. Key: AP, denotes that the P2X
receptors are localized on the epithelial cell apical membrane;
BL, denotes localization on the basolateral membrane; ADPKD,
autosomal dominant polycystic kidney disease; DN, diabetic
nephropathy; VSMC, vascular smooth muscle cell; DVR, descending
vasa recta.
P2XR subtypes mediating the single-channel activity is a cur-
rent focus of the group. Initial observations in rat CD principal
cells in vitro demonstrated that apical P2X4R modulates ENaC
(epithelial Na channel) activity: high concentrations of lumi-
nal ATP evoked P2X4R-mediated inhibition of ENaC activity,
whereas low concentrations conversely potentiated ENaC activ-
ity (Wildman et al., 2008). In addition to our in vitro functional
data we have used P2X4R−/− mice to demonstrate an in vivo role
for P2X4R in Na reabsorption and salt sensitivity (Craigie et al.,
2012). Data from our most recent in vivo renal clearance stud-
ies have revealed a raised mean arterial blood pressure (MABP)
in P2X4R−/− when compared with wild-type (WT) littermates.
When dietary Na was altered to what is termed a low Na diet
(0.03% compared to 0.3% in a standard diet), the reduction in
dietary Na significantly reduced MABP in the P2X4R−/− but
not in WT. Interestingly, when comparing the ENaC-mediated
reabsorption for WT and P2X4R−/− on a standard diet there
was no significant difference. However, when on a low Na diet
the P2X4R−/− mice exhibited a significantly reduced fractional
Na excretion compared with WT, indicating this group of ani-
mals were unable to increase ENaC-mediated Na reabsorption
in the absence of P2X4R. These data collectively suggest that
P2X4R−/− mice have salt-sensitive blood pressure and are unable
to increase their ENaC-mediated sodium reabsorption when
dietary sodium is low. The latter finding is compatible with our
previous in vitro data that describes a P2X4-mediated potenti-
ation of ENaC activity when extracellular sodium is low. Thus,
P2X4 may act as an intrinsic regulator of ENaC activity in the
aldosterone-sensitive distal nephron to moderate Na reabsorp-
tion in response to changes is Na load. Perhaps of note, in vivo
pharmacological studies performed in rats, whereby P2XR ago-
nists were intravenously infused showed a marked, progressively-
increasing diuresis, together with an increase in the Na excretion
rate. Authors concluded that activation of P2XR increased renal
Na and water excretion in rats via a Na-K-ATPase-dependent
mechanism (Jankowski et al., 2011). Evidently, P2X4R in the CD
may feature in the complexity of essential hypertension.
Whilst the precise mechanism(s) responsible for P2XR-
mediated increases in Na excretion require clarification, the evi-
dence in favor of significant functional roles for P2XR in the
nephron is increasing. This is further confirmed by pathophys-
iological findings that provide evidence for the involvement of
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P2XR in kidney dysfunction. P2X4R have been highlighted as
key receptors in inflammasome activation and have been linked
to diabetic nephropathy (DN) (Chen et al., 2013). It is well-
established that tubulointerstitial inflammation is involved in
the development of DN, and is mediated by key inflammatory
cytokines. Chen and colleagues demonstrated that extracellular
ATP causes P2X4R to activate the NOD-like receptor 3 (NLRP3)
inflammasome, causing cytokine maturation and release (Chen
et al., 2013). In light of the potential link between P2X4R, inflam-
masome activation, and DN, P2X4R signaling in NLRP3 inflam-
masomes was investigated using renal biopsies from patients with
type-2 diabetes. Authors reported increased expression of P2X4R
in renal tubular epithelial cells of patients with type-2 diabetes
compared with non-diabetic patients, and that P2X4R expression
correlated with expression of IL-1 and IL-18 (Chen et al., 2013).
This finding is perhaps not surprising since ATP is one of the
best established damage-associated molecular patterns (DAMPs),
and as such plays an important role in inflammation and immu-
nity by functioning as a signal of cell damage, stress or death
during injury and disease (Chen and Nunez, 2010). A cautionary
note: whilst these studies substantiate the hypothesis that P2X4R
blockade would be a successful therapeutic strategy in attenuat-
ing DN, there is evidence to suggest this may lead to hypertension
by disrupting sodium transport in the distal nephron (as pre-
viously discussed). This highlights the fact that although P2XR
have emerged as attractive therapeutic targets for many patho-
physiological conditions, their widespread expression and diverse
roles means the manipulation of these receptors is extremely
complex.
Activation of P2X7R (albeit via a more established mecha-
nism), like P2X4R, induces downstream inflammatory events,
including the NALP3 inflammasome/caspase-1-dependent mat-
uration of IL-1β and IL-18, and their subsequent release from
various myeloid cell types (Idzko et al., 2007). There is now
also evidence for Madin-Darby canine kidney (MDCK) epithelial
cells expressing functional P2X7R, as well as TLR4 and molecules
associated with the NALP3 inflammasome (Jalilian et al., 2012),
perhaps highlighting their importance in renal inflammatory
injury and renal disease. P2X7R are perhaps the P2XR subtype
most linked to pathophysiology of the kidney. Historically, P2X7R
(which can form pores under certain circumstances) are known
to be pro-inflammatory, and whilst they are extensively expressed
in cells of the immune system they are not highly expressed in
healthy kidney tissue (Hillman et al., 2005). Recent additional
lines of evidence that describe alternative roles for P2X7R in kid-
ney dysfunction have revealed a role for P2X7R in: the disrupted
calcium homeostasis in peripheral blood mononuclear cells of
chronic kidney disease patients (Lajdova et al., 2012), P2XR-
mediated cytogenesis in polycystic kidney disease (Chang et al.,
2011), interstitial fibroblast cell death following ATP release from
necrotic renal epithelial cells (Ponnusamy et al., 2011), and a cru-
cial role in driving hypertension and renal injury (Ji et al., 2012b).
It seems that both P2X4R and P2X7R are evermore commonly
associated with kidney dysfunction. With this in mind we have
utilized P2X4R−/− and P2X7R−/− mouse models and noted that
in the P2X4R−/−, mRNA for P2X7R was reduced and vice versa,
which collectively indicates an interaction of P2X4R with P2X7R
at the expressional level to (patho)physiologically regulate renal
function (Birch et al., 2013b; Craigie et al., 2013). The specific
role of P2XR in renal pathophysiology will be discussed below in
greater detail.
NEW ROLES FOR P2XR AND RENAL VASCULATURE
In addition to tubular epithelial cell expression, P2R are expressed
in renal vascular and glomerular cells of the medulla and cor-
tex (Bailey et al., 2012). The role of P2R in renal vasculature is
complex and dependent on many factors including species, vas-
cular tone, and variable P2R expression patterns. Despite this,
numerous functional studies have previously established that P2R
have a regulatory role in the renal vasculature (Inscho et al.,
1992; Weihprecht et al., 1992; Eltze and Ullrich, 1996; Inscho,
2001; Rost et al., 2002; Eppel et al., 2006a). Much of the his-
torical evidence surrounding a role for P2XR in the regulation
of renal blood flow focuses on the P2X1R, most likely a reflec-
tion of this being the key receptor expressed by vascular smooth
muscle cells (VSMCs). P2X1R are expressed in afferent arterioles
but not in efferent arterioles (Osmond and Inscho, 2010) and
functional data suggest that ATP-mediated activation of P2X1R
represents an important mechanism for regulating renal blood
flow and glomerular capillary pressure by regulating afferent
arteriolar resistance and in pressure-dependent autoregulatory
adjustments in afferent arteriolar diameter (Inscho et al., 2003).
In vivo studies in which rabbits were infused intrarenally with
α, β-methylene ATP described a reduction in both cortical and
medullary blood flow that implicated P2XR in the regulation of
regional renal blood flow (Eppel et al., 2006b). The interpre-
tation of these former studies have, however, been challenged
by recent mouse micropuncture experiments, that have raised
questions as to the role of P2XR specifically in tubuloglomeru-
lar feedback (TGF), which is the mechanism responsible for
matching glomerular filtration to perfusion in the loop of Henle
(Schnermann, 2011). The author of this study reported that both
intravenous infusion and luminal perfusion of inhibitors of P2R
(at a dose that significantly reduced the blood pressure response
to α, β-methylene ATP), failed to affect the TGF response to
saturating increases in loop perfusion rate. Moreover, macula
densa release of nucleotides appeared not to be involved in the
vasoconstriction that accompanies increased loop flow in vivo
(Schnermann, 2011). These findings are in contrast to an in vivo
study in which anaesthetized rats were treated with Ip5I, a potent
P2X1R antagonist, and showed a significant loss of autoregula-
tory ability, whereas in anaesthetized rats treated with DPCPX,
a potent A1R antagonist, autoregulatory control of renal blood
flow remained intact (Osmond and Inscho, 2010). The dispar-
ity noted above may reflect the acknowledged differences in the
relative expression of P2XR between species. Collectively these
data suggest that P2X1R are implicated in renal autoregulatory
(and maybe not TGF) responses, although the relative contribu-
tion of P2XR to these complex physiological processes requires
further clarification and may be species dependent. Furthermore,
it is possible that ATP and adenosine signaling pathways integrate
to mediate TGF. ATP released in response to increased perfu-
sion pressure and/or increases in tubular concentrations could
mediate vasoconstriction of the afferent arteriole via P2XR, but
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might also be dephosphorylated to form adenosine, which may
compound the afferent arteriole vasoconstriction.
In a recent study utilizing the live kidney slice model to inves-
tigate regulation of medullary blood flow (MBF) we reported a
role for P2XR (and P2YR) in the regulation of vasa recta diameter
via contractile pericytes (Crawford et al., 2011). Data described
an ATP-mediated constriction of in situ vasa recta via contractile
pericytes and also demonstrated attenuation of the ATP-mediated
constriction in the presence of the P2XR antagonist PPADS.
Additionally pericytes constricted vasa recta diameter when live
slices were superfused with 2meSATP and BzATP, which act at
P2XR. PCR experiments performed on isolated vasa recta to
investigate P2R mRNA expression combined with the pharma-
cological data acquired in functional experiments indicated a
putative role for both P2X1R and P2X7R in the regulation ofMBF
(Crawford et al., 2011). Since pericytes are considered to be rel-
atively undifferentiated having the ability to differentiate further
in to VSMCs, it is interesting to note that calcium entry via P2XR
has also recently been implicated in the contractile mechanism
of renal VSMCs isolated from arcuate arteries and interlobular
arteries (Povstyan et al., 2011), thus providing additional evidence
for P2XR having a functional role in mediating VSMC contrac-
tion in other vascular cells of the kidney. Regarding the functional
role of P2XR in pericytes per se, P2XR (particularly P2X7R) have
also been implicated in the regulation of the retinal pericytes
(Sugiyama et al., 2004, 2005) and in the regulation of pericytes
of spiral ligament capillaries in the cochlea (Wu et al., 2011).
Given the established role for P2XR in the regulation of vas-
cular cells throughout the body it is not surprising that there are
emergent studies in the renal field also highlighting their signifi-
cance in renal blood flow regulation. What is striking, however,
is the accumulating evidence that points toward P2XR playing
a critical role in renal pathophysiology, whether the etiology is
vascular or tubular in origin.
P2XR AND RENAL PATHOPHYSIOLOGY
With current funding bodies placing ever increasing importance
on translational “bench to bedside” research it is particularly
exciting when a molecule or group of molecules emerge as having
prominent roles in organ pathology. As eluded to already in this
article, there is a compelling mass of evidence that indicates P2XR
play crucial and divergent roles in renal pathophysiology. As such,
P2XR now represent novel putative targets for renal disease inter-
vention and treatment strategies (North and Jarvis, 2013), and
are currently the subject of avid investigation by multiple major
international pharmaceutical companies.
Much of the current focus on the potential role of P2XR in
renal disease is focused on the homomeric P2X7R, this ligand-
gated cation channel being unique in terms of both its structure
and function. Unlike its other family members it is thought to
exist only as a homomer and has an extended C-terminus with
200 extra amino acid residues, which is thought to be pivotal in
regulating its function, being involved in: determining cellular
localization, stimulation of various signaling cascades, protein-
protein interactions, and post-translational modification of the
receptor itself (Costa-Junior et al., 2011). Sustained stimulation
of P2X7R with high agonist concentrations (mM) is classically
associated with the formation of large transmembrane pores that
disrupt the ion gradients within cells resulting in subsequent cell
death by either apoptosis or necrosis (Surprenant et al., 1996).
The P2X7R is typically expressed by immune cells and mediates
release of pro-inflammatory cytokines, prominently interleukin-
1 beta (IL-1β), via activation of caspase 1 (Ferrari et al., 1997;
Costa-Junior et al., 2011). In contrast to the healthy kidney
in which P2X7R is virtually undetected, P2X7R expression is
readily detected in inflammatory renal diseases, such as glomeru-
lonephritis (Vonend et al., 2004). The role of P2X7R in renal
pathophysiology is not however limited to inflammatory disease.
Indeed current topical studies demonstrate that P2X7R plays a
detrimental role in a broad range of renal pathologies that will be
discussed below.
A recent study has suggested that the pro-inflammatory nature
of P2X7R could contribute to the development of hypertension
and consequential renal injury. The functional role of P2X7R in
hypertension was investigated using WT and P2X7−/− mice ren-
dered hypertensive by a high salt diet and deoxycorticosterone
acetate (DOCA) treatment (Ji et al., 2012b). After DOCA-salt
treatment, P2X7R mRNA and protein expression was increased
in WT mice, accompanied by a greater increase in systolic blood
pressure (SBP), significantly greater than that of P2X7−/− mice.
Inflammatory cell infiltration was reduced in P2X7−/− mice,
and IL-1β release from macrophages was inhibited. Furthermore,
the downstream effectors of IL-1β signaling, COX-2 and ROS
were also affected; COX-2 expression being reduced in P2X7−/−
mice and anti-oxidant levels being increased in their serum.
Authors of the study suggested that blockade of the P2X7R-
mediated inflammatory responses protect renal function against
P2X7R-associated renal injury, this being reflected by reduced
albuminuria and renal interstitial fibrosis, and increased creati-
nine clearance (Ji et al., 2012b).With regard to hypertension, both
WT and P2X7−/− exhibited initial increases in SBP following
DOCA-salt treatment, and only at day-4 of treatment were differ-
ences in SBP observed between the two animal groups; P2X7−/−
mice having significantly lower SBP than WT mice. This study
built on previous observations demonstrating that immune cell
infiltration was pivotal to the development of salt-sensitive hyper-
tension (Franco et al., 2007), authors of this preceding study
reported P2X7R expression by immune cells exacerbated renal
injury by instigating a vicious cycle of inflammation. Additional
in vivo evidence to support this has been attained from phar-
macological studies performed in Dahl salt-sensitive (DS) rats
(Ji et al., 2012a). Hypertensive rats were infused with two P2X7R
selective antagonists (brilliant blue G and A-438079); the salt-
sensitive hypertension, urinary protein or albumin excretion,
renal interstitial fibrosis, and macrophage and T-cell infiltration
in the DS rats was markedly reduced, whilst creatinine clearance
significantly improved (Ji et al., 2012a). Collectively these novel
studies provide persuasive evidence that the P2X7R is critical in
hypertension and renal injury progression, thus highlighting the
therapeutic potential for this receptor in a number of disease
states underlying salt-sensitive hypertension, including but not
limited to, hyperaldosteronism.
As previously mentioned, blockade of P2X7R has been shown
to inhibit IL-1β release from renal macrophages (Ji et al., 2012b),
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and this may have significant consequences for the underlying
mechanisms of certain forms of renal disease. Renal fibroblasts
are activated by IL-1β amongst other cytokines and due to the
P2X7R/IL-1β axis it seems pertinent to assume P2X7R-mediated
attenuation of fibroblast activation could occur. Whilst this may
have beneficial effects in terms of reducing renal interstitial fibro-
sis, activation of renal fibroblasts post acute kidney injury (AKI)
is vital for normal renal repair. AKI is typically characterized by
renal tubular cell death and associated release of high concentra-
tions of ATP into the interstitium, combined with the associated
damage to the tubular basement membrane, to which interstitial
fibroblasts are directly connected; this milieu provides an ideal
setting for P2X7R to play a prominent role in either AKI associ-
ated fibrosis or renal repair. To investigate this paradigm, a recent
study investigated the effects of supernatant from necrotic renal
proximal tubular cells (RPTC) on the viability of renal fibroblasts
(Ponnusamy et al., 2011). The supernatant from necrotic RPTC
was shown to induce the expression of P2X7R in cultured rat renal
interstitial fibroblast cells (NRK-49F), and the ATP released from
necrotic RPTC inducedNRK-49F cell death by a P2X7R-mediated
mechanism, therefore demonstrating a deleterious direct renal
epithelial-fibroblast cross-talk pathway (Ponnusamy et al., 2011).
It was concluded that damaged renal epithelial cells could directly
induce the death of renal interstitial fibroblasts by ATP activa-
tion of P2X7R. This evidence was not, however, in accordance
with a previous study which showed that the number of Epo-TAg
(a genetic marker for cortical interstitial fibroblasts) expressing
fibroblasts is reduced in the injured kidney, but upon intense
stimulation such as severe anemia or hypoxia, there was a greater
increase in Epo-TAg expressing fibroblasts in the injured kid-
ney which consequently narrowed the disproportion between the
injured and uninjured kidney. Authors conclude that rather than
fibroblasts being destroyed in the event of AKI, the threshold for
stimulated gene expression is increased (Maxwell et al., 1997),
which could possibly be mediated by P2X7R. So it is unclear if
AKI results in a reduced number of renal interstitial fibroblasts or
an alteration in cell properties.
Renal interstitial fibroblasts have both beneficial and delete-
rious effects on the kidney by playing a key role in renal repair
and renal fibrosis, respectively. Consequently, interstitial fibrob-
last cell proliferation, activation, and death are tightly regulated
by numerous factors. It is certainly plausible that ATP is one
such factor and P2X7R is an important mediator. It has been
shown in vitro that P2X7R activation directly influences intersti-
tial fibroblast cell death (Ponnusamy et al., 2011). However, the
possibility exists that P2X7R also indirectly influences fibroblast
activation by inducing IL-1β release from infiltrating immune
cells (Ji et al., 2012b). Both studies propose P2X7R as a ther-
apeutic target. Although pharmacological blockade of P2X7R
was highly effective at attenuating renal fibrosis, the implica-
tions this may have on the repair response post-AKI need to be
considered.
Lastly, in addition to the pro-inflammatory and pro-death
functions of P2X7R discussed in preceding paragraphs there
seems also to be a role for P2X7R in autosomal dominant polycys-
tic kidney disease (ADPKD). This common, yet complex, genetic
renal disease occurs in response to mutations in either the PKD1
or PKD2 gene (Mochizuki et al., 2013), and is characterized by
progressive cyst enlargement due to excess fluid secretion and
proliferation of renal tubular epithelial cells (Torres et al., 2009).
Whilst this condition is a major cause of end stage renal disease,
there still lacks a clinically approved therapy, primarily due to the
slow progression of the disease and complexity of its develop-
ment. The current focus is to assess the potential of combination
therapies targeting either cyst development through inhibition
of cell proliferation, and/or cyst growth through attenuation of
fluid secretion. Recent data yielded from the zebrafish model
of ADPKD where PKD2 is knocked-down, described increased
P2X7R mRNA expression at an early stage, which coincided with
cyst formation in the glomerulus and tubular regions in 75%
of PKD2 morphants. Pharmacological blockade with a P2X7R
antagonist OxATP reduced the frequency of cyst formation to
35%, suggesting that P2X7R contributes in some way to cyst
formation in ADPKD (Chang et al., 2011). PKD2 morphants
demonstrate increased ERK activation in primary cilia, which is
linked to enhanced cell proliferation and fluid secretion and hence
cyst enlargement in PKD. Previous studies have demonstrated
that P2X7R acts as a flow sensor for ERK activation in osteoblasts
(Okumura et al., 2008). Given that authors describe inhibition
of P2X7R as suppressing the elevated ERK activation in PKD2
morphants by over 50%, coupled with the fact cilium bending
has been shown to trigger ATP release, suggests a similar P2X7R-
coupled mechanism may be present in renal epithelial cells. This
hypothesis is further substantiated by findings that demonstrated
inhibition of P2X7R did not suppress cyst progression through
the traditional anti-inflammatory mechanism (Chang et al., 2011;
Praetorius and Leipziger, 2013). Whilst extremely novel, these
data are, however, at odds with previously published data col-
lected from studies using the MDCK model of cyst formation.
Here authors agreed that ERK activation is an important factor
in cyst growth. However, they found no evidence for the involve-
ment of a P2XR, and concluded that a P2YR is responsible for
cAMP-dependent activation of the ERK pathway and cyst growth
(Turner et al., 2007).
SUMMARY
P2XR represent a receptor group important in the regulation of
tubular and vascular function in both kidney health and dis-
ease (see Figures 1, 2 for a summary). Much of the recent data
providing compelling functional evidence that substantiate this
phenomenon has been generated from knockout mouse stud-
ies, which further attests to the importance of these models in
improving our knowledge of how kidney function is regulated.
As a result of these studies there appear to be three key P2XR
subunits/subtypes, P2X1, 4, and 7, which have emerged as hav-
ing numerous roles in the regulation of kidney function. As such,
these receptor subtypes not only represent favorable novel thera-
peutic targets in multiple pathological settings, but also represent
a novel focus for future research on the role of nucleotides in the
kidney.
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